8049 Stock Overview
Manufactures and distributes Chinese medicines and pharmaceutical products in the People’s Republic of China. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Jilin Province Huinan Changlong Bio-pharmacy Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$2.05 |
| 52 Week High | HK$2.13 |
| 52 Week Low | HK$1.20 |
| Beta | 0.23 |
| 1 Month Change | 21.30% |
| 3 Month Change | 22.75% |
| 1 Year Change | 41.38% |
| 3 Year Change | 72.27% |
| 5 Year Change | 24.24% |
| Change since IPO | 47.48% |
Recent News & Updates
Recent updates
Here's Why Jilin Province Huinan Changlong Bio-pharmacy (HKG:8049) Has Caught The Eye Of Investors
Apr 29
Here's Why Shareholders May Consider Paying Jilin Province Huinan Changlong Bio-pharmacy Company Limited's (HKG:8049) CEO A Little More
May 21There May Be Reason For Hope In Jilin Province Huinan Changlong Bio-pharmacy's (HKG:8049) Disappointing Earnings
Apr 04With EPS Growth And More, Jilin Province Huinan Changlong Bio-pharmacy (HKG:8049) Makes An Interesting Case
Mar 26Investors Don't See Light At End Of Jilin Province Huinan Changlong Bio-pharmacy Company Limited's (HKG:8049) Tunnel
Dec 27With EPS Growth And More, Jilin Province Huinan Changlong Bio-pharmacy (HKG:8049) Makes An Interesting Case
Jul 12It's Unlikely That Shareholders Will Increase Jilin Province Huinan Changlong Bio-pharmacy Company Limited's (HKG:8049) Compensation By Much This Year
Jun 05How Is Jilin Province Huinan Changlong Bio-pharmacy's (HKG:8049) CEO Paid Relative To Peers?
Nov 26Shareholder Returns
| 8049 | HK Pharmaceuticals | HK Market | |
|---|---|---|---|
| 7D | 9.6% | -0.2% | 3.8% |
| 1Y | 41.4% | 6.5% | 14.6% |
Return vs Industry: 8049 exceeded the Hong Kong Pharmaceuticals industry which returned 5.2% over the past year.
Return vs Market: 8049 exceeded the Hong Kong Market which returned 12.6% over the past year.
Price Volatility
| 8049 volatility | |
|---|---|
| 8049 Average Weekly Movement | 9.5% |
| Pharmaceuticals Industry Average Movement | 7.5% |
| Market Average Movement | 8.1% |
| 10% most volatile stocks in HK Market | 15.5% |
| 10% least volatile stocks in HK Market | 4.2% |
Stable Share Price: 8049 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 8049's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 745 | Hong Zhang | www.jlchanglong.com |
Jilin Province Huinan Changlong Bio-pharmacy Company Limited manufactures and distributes Chinese medicines and pharmaceutical products in the People’s Republic of China. The company provides Edaravone injection, compound brain comfort capsules, haikun kidney hi capsules, cefpirome sulfate for injections, Cefpiramide for injections, anti-bone hyperplasia tablets, Lysine zinc gluconate tablets, and Qianlie Guihuang Tablets. It markets its products under the Changlong and Qing Tong brands.
Jilin Province Huinan Changlong Bio-pharmacy Company Limited Fundamentals Summary
| 8049 fundamental statistics | |
|---|---|
| Market cap | HK$1.15b |
| Earnings (TTM) | HK$199.60m |
| Revenue (TTM) | HK$954.55m |
5.8x
P/E Ratio1.2x
P/S RatioIs 8049 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 8049 income statement (TTM) | |
|---|---|
| Revenue | CN¥881.16m |
| Cost of Revenue | CN¥195.91m |
| Gross Profit | CN¥685.25m |
| Other Expenses | CN¥501.00m |
| Earnings | CN¥184.25m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.33 |
| Gross Margin | 77.77% |
| Net Profit Margin | 20.91% |
| Debt/Equity Ratio | 4.4% |
How did 8049 perform over the long term?
See historical performance and comparisonDividends
3.3%
Current Dividend Yieldn/a
Payout RatioDoes 8049 pay a reliable dividends?
See 8049 dividend history and benchmarks| Jilin Province Huinan Changlong Bio-pharmacy dividend dates | |
|---|---|
| Ex Dividend Date | Jun 24 2025 |
| Dividend Pay Date | Jul 18 2025 |
| Days until Ex dividend | 40 days |
| Days until Dividend pay date | 64 days |
Does 8049 pay a reliable dividends?
See 8049 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/14 05:07 |
| End of Day Share Price | 2025/05/14 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Jilin Province Huinan Changlong Bio-pharmacy Company Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ssu-Han Fu | Jih Sun Securities Investment Consulting Co., Ltd. |